Parkinsonism proteolysis and proteasomes.
Parkinsonism proteolysis and proteasomes.
复制标题
帕金森病蛋白水解和蛋白酶体。
DOI:
10.1038/sj.cdd.4401026
复制
发表时间:
2002
影响因子:
12.4
通讯作者:
Wang,Z
中科院分区:
文献类型:
--
作者:
Schwartz,LM;Nambu,JR;Wang,Z
It is a general truism of science that the left hand side of an equation always attracts more attention than the right. The left hand side represents synthesis, while the right-hand side is dismissed as inactivation, a step-back from the can-do approach. Mitosis, transcription, translation and phosphorylation all attracted earlier and keener interest than did apoptosis, nucleases, proteases or phosphatases. With time however, further investigation always reveals that both sides play essential roles in the careful balance of regulation. The steady-state number of cells or molecules at any given time represents a balance between synthesis and degradation. Alter either and the balance shifts. Since most biological processes are controlled by the activity of specific proteins, the field of proteolysis has recently attracted considerable interest in the study of cellular regulation and molecular pathology. The ubiquitinąproteasome system (UPS), once dismissed as the cell'sgarbage disposal', is now appreciated as the complex, elegantly regulated pathway that is responsible for the selective degradation of specific proteins (reviewed in 1). Subtle perturbations in this pathway lead to the inappropriate stabilization or degradation of key signaling molecules, which in turn can result in pathology. 2 For example, selective ubiquitination of the tumor suppressor protein p53 by papilloma virus E6 protein and the cellular E6-Associated Protein (E6-AP), leads to proteasome-dependent p53 degradation and enhanced rates of cervical cancer. 3 While a direct role for the UPS and disease has been well established for cancer it has been less clear if aberrations in this pathway are responsible for initiating neurodegenerative disorders. In this review, we describe the UPS and summarize recent findings directly linking defects in the UPS and the initiation of Parkinsonism.Ubiquitinąprotein conjugation is an ATP-dependent process that is mediated by three distinct classes of enzymes1(Figure 1). First in the cascade is the E1 ubiquitin-activating enzyme, which initially forms a thiolester bond with ubiquitin. Ubiquitin is then transferred to one of a number of E2 ubiquitin-conjugating enzymes (UBCs). Each species carry multiple independent E2 genes that serve unique cellular roles and the different E2 proteins cannot functionally substitute for one another. 4 The last enzyme in the cascade is the E3 ubiquitinąprotein ligase, which